---
title: "SSMD Agrotech India Ltd (544621) — Share Price, Financials & Analysis"
symbol: "544621"
company: "SSMD Agrotech India Ltd"
canonical: "https://tapetide.com/stocks/544621"
isin: "INE1U2R01013"
nse_symbol: "SSMDAGROTECHINDIALTD"
bse_code: "544621"
sector: "Food Products"
industry: "Packaged Foods"
market_cap_cr: 57.1
generated_at: "2026-09-13T18:58:59.268Z"
---

# SSMD Agrotech India Ltd (544621)

Canonical page: https://tapetide.com/stocks/544621

## Company

- **NSE Symbol:** SSMDAGROTECHINDIALTD
- **BSE Code:** 544621
- **ISIN:** INE1U2R01013
- **Sector:** Food Products
- **Industry:** Packaged Foods
- **Macro Sector:** Fast Moving Consumer Goods
- **Stock Type:** EQUITY
- **Listed Since:** 2025-12-02
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** houseofmanohar.com

## About

SSMD Agrotech India Ltd is engaged in the manufacturing, trading, and repacking of a wide array of high quality agrofood products.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:54:23.225910Z.

- **Market Cap:** ₹57.1 Cr
- **Classification:** SME
- **P/E (reported):** 0
- **Book Value:** ₹46.06
- **Price to Book:** 1.26
- **Dividend Yield:** 0%
- **ROE:** 13.85%
- **ROCE:** 19.85%
- **Debt to Equity:** 0.03
- **Revenue (yearly):** ₹115.7 Cr
- **Net Income:** ₹5.5 Cr
- **EBITDA:** ₹8.6 Cr
- **52-Week High:** ₹80.45
- **52-Week Low:** ₹30.1
- **RSI (14):** 45.83

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 40.5%

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 43.3 to 57.2 days.
- Working capital days have increased from 32.3 days to 82.8 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | -514.63% | — | -696.88% |
| ebitda margin growth | -14.02% | 545.22% | — |
| net income growth | 1.85% | — | — |
| revenue growth | 16.63% | 274.66% | — |
| roce | -80.38% | -77.73% | — |
| roe | -82.18% | 51.99% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Mar 2026 |
| --- | --- | --- |
| Sales | 63 | 115 |
| Expenses | 61 | 107 |
| Operating Profit | 2 | 8 |
| OPM % | 3.9 | 7 |
| Other Income | 0 | 0 |
| Interest | 0 | 1 |
| Depreciation | 0 | 0 |
| Profit before tax | 2 | 7 |
| Tax % | 27 | 26 |
| Net Profit | 2 | 6 |
| EPS in Rs | 31.78 | 6.38 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Sales | 2 | 99 | 115 |
| Expenses | 2 | 91 | 107 |
| Operating Profit | 0 | 9 | 9 |
| OPM % | 1.4 | 9 | 7 |
| Other Income | 0 | 0 | 0 |
| Interest | 0 | 1 | 1 |
| Depreciation | 0 | 0 | 0 |
| Profit before tax | 0 | 7 | 7 |
| Tax % | 33 | 27 | 26 |
| Net Profit | 0 | 5 | 6 |
| EPS in Rs | 20 | 101.18 | 6.38 |
| Dividend Payout % | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Equity Capital | 0.01 | 0.53 | 9 |
| Reserves | 0 | 6 | 31 |
| Borrowings | 0 | 6 | 1 |
| Other Liabilities | 1 | 5 | 8 |
| Total Liabilities | 1 | 18 | 49 |
| Fixed Assets | 0 | 2 | 2 |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 1 | 16 | 48 |
| Total Assets | 1 | 18 | 49 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 2 | -10 |
| Cash from Investing Activity | 0 | -1 | 0 |
| Cash from Financing Activity | 0 | -1 | 22 |
| Net Cash Flow | 0 | 1 | 12 |
| Free Cash Flow | 0 | 2 | -11 |
| CFO/OP | 200 | 52 | -96 |

### Ratios

| Item | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- |
| Debtor Days | 61 | 11 | 57 |
| Inventory Days | 28 | 50 | 55 |
| Days Payable | 101 | 11 | 20 |
| Cash Conversion Cycle | -12 | 50 | 93 |
| Working Capital Days | -5 | 19 | 83 |
| ROCE % | — | 125 | 31 |

## Shareholding Pattern

### Quarterly

| Category | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- |
| Promoters | 67.49% | 67.84% | 68.24% |
| FIIs | 0% | 0% | 0% |
| DIIs | 1.6% | 1.6% | 1.6% |
| Government | 0% | 0% | 0% |
| Public | 23.39% | 21.3% | 20.88% |
| Others | 7.51% | 9.25% | 9.28% |
| No. of Shareholders | 1128 | 709 | 637 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 9 / 8 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 60.63 | Buy |
| EMA (10) | 60.63 | Buy |
| SMA (20) | 60.31 | Buy |
| EMA (20) | 60.55 | Buy |
| SMA (50) | 61.42 | Buy |
| EMA (50) | 60.94 | Buy |
| SMA (100) | 62.06 | Sell |
| EMA (100) | 60.04 | Buy |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 52.29 | Neutral |
| MACD (12,26,9) | -0.07 | Buy |
| Stochastic (14,3,3) | 58.86 | Neutral |
| ADX (14) | 11.5 | Neutral |
| Williams %R (14) | -36.45 | Neutral |
| ATR (14) | 3.87 | High Volatility |
| ROC (12) | 12.5 | Buy |
| Stoch RSI (14) | 91.44 | Sell |
| UO (7,14,28) | 41.76 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69b81e89-9302-46f8-a7df-544386461fdf.pdf) |
| 2026-07-14 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4b8e708-e834-4e8e-8706-24bae978e5e5.pdf) |
| 2026-07-06 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d921539-e7ce-4e13-a82d-dd2f81f0c72d.pdf) |
| 2026-07-05 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b72cf6b-f57a-4378-a0af-e7bdf9ba8d67.pdf) |
| 2026-07-05 | [Announcement under Regulation 30 (LODR)-Meeting Updates](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33882568-b707-4213-9748-d82aba212cc4.pdf) |
| 2026-06-23 | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02fa0525-8513-4807-abcc-5be417fa6b2b.pdf) |
| 2026-06-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ca95e11-211a-457a-acbf-e2436814cd28.pdf) |
| 2026-06-12 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3460d6e-72f6-488c-8519-d691be0b157d.pdf) |
| 2026-06-12 | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f323eadf-097d-4030-ab83-37faa8c3a143.pdf) |
| 2026-06-12 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e739ae83-436c-4a3e-adf2-216f19522778.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 Apr - MD Ishu Munjal acquired 56,000 shares in March 2026; holding rose to 67.49%. | [Acquisition Of Equity Shares By The Promoter 7 Apr - MD Ishu Munjal acquired 56,000 shares in March 2026; holding rose to 67.49%.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9e55137e-643e-4f68-a2ab-79c5e3031d66.pdf) |
| 6 Mar - 06 Mar 2026: SSMD commenced maize import and launched 'Manohar Agro Popcorn' under House of Manohar. | [Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 6 Mar - 06 Mar 2026: SSMD commenced maize import and launched 'Manohar Agro Popcorn' under House of Manohar.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6cbf58cb-d3c6-4863-a79c-564b23d7cff7.pdf) |
| 6 Apr - Whole-time Director resigned; Vandana Munjal appointed Executive Additional Director; corporate office shifted; secretarial auditor ratified. | [Announcement under Regulation 30 (LODR)-Change in Management 6 Apr - Whole-time Director resigned; Vandana Munjal appointed Executive Additional Director; corporate office shifted; secretarial auditor ratified.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eae2f438-72a1-456f-9edd-8fa457bcdac3.pdf) |
| 6 Apr - On 6 Apr 2026, Ms. Surbhi Munjal resigned; Mrs. Vandana Munjal appointed Executive Additional Director at ₹1 lakh/month. | [Board Meeting Outcome for Outcome Of Board Meeting 6 Apr - On 6 Apr 2026, Ms. Surbhi Munjal resigned; Mrs. Vandana Munjal appointed Executive Additional Director at ₹1 lakh/month.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3b047e87-82d7-4bf0-9af4-d11213cbc970.pdf) |
| 6 Apr - Company shifted corporate office to North West Delhi effective 06 April 2026; registered office unchanged. | [Announcement under Regulation 30 (LODR)-Change in Corporate Office Address 6 Apr - Company shifted corporate office to North West Delhi effective 06 April 2026; registered office unchanged.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6a1ce676-a074-4d68-8d3e-adf8f0c9e9ab.pdf) |
| 26 Mar - Whole-Time Director Surbhi Munjal resigned; effective upon board acceptance; resignation dated 26 March 2026. | [Announcement under Regulation 30 (LODR)-Resignation of Director 26 Mar - Whole-Time Director Surbhi Munjal resigned; effective upon board acceptance; resignation dated 26 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4d12e372-9d14-4ec2-a9e5-72e621831e31.pdf) |
| 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited FY2026 results. | [Closure of Trading Window 26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited FY2026 results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5c3a263c-4599-4fc1-8ba1-20963c4f4722.pdf) |
| 16 Nov 2015 - Pharmaceuticals Ltd has informed BSE regarding a Press Release dated November 16, 2015 titled "Shasun Pharmaceuticals receives USFDA approval for Carisoprodol Tablets". | [Shasun Pharmaceuticals receives USFDA approval for Carisoprodol Tablets 16 Nov 2015 - Pharmaceuticals Ltd has informed BSE regarding a Press Release dated November 16, 2015 titled "Shasun Pharmaceuticals receives USFDA approval for Carisoprodol Tablets".](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2015/11/1A9EA5E6_858E_4347_AF80_7DA300DA4796_111641.pdf) |
| 15 Feb - Board approved internal auditor change, authorized MD to sign MOU with Demeter, and ₹5 Cr OD facility. | [Board Meeting Outcome for Outcome Of Board Meeting Held On 14.02.2025 15 Feb - Board approved internal auditor change, authorized MD to sign MOU with Demeter, and ₹5 Cr OD facility.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b68942a7-cd3a-4342-8fd9-c7c0e2855e94.pdf) |
| 14 Feb - Monitoring report for SSMD's Rs.34.09Cr IPO; Rs.3.96Cr used, Rs.23.10Cr unutilized as of 31-Dec-2025. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 14 Feb - Monitoring report for SSMD's Rs.34.09Cr IPO; Rs.3.96Cr used, Rs.23.10Cr unutilized as of 31-Dec-2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7c84db7d-5804-47cf-bd94-1ad52d034eb9.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2012 from nse](https://archives.nseindia.com/annual_reports/AR_SHASUNPHAR_2011_2012_30072012150910.zip) |
| from nse | [Financial Year 2010 from nse](https://archives.nseindia.com/annual_reports/AR_SHASUNPHAR_2009_2010_13042011125621.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e739ae83-436c-4a3e-adf2-216f19522778.pdf) |
| from bse | [Financial Year 2015 from bse](https://www.bseindia.com/bseplus/AnnualReport/524552/5245520315.pdf) |
| from bse | [Financial Year 2014 from bse](https://www.bseindia.com/bseplus/AnnualReport/524552/5245520314.pdf) |
| from bse | [Financial Year 2013 from bse](https://www.bseindia.com/bseplus/AnnualReport/524552/5245520313.pdf) |
| from bse | [Financial Year 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport/524552/5245520312.pdf) |
| from bse | [Financial Year 2011 from bse](https://www.bseindia.com/bseplus/AnnualReport/524552/5245520311.pdf) |
| from bse | [Financial Year 2010 from bse](https://www.bseindia.com/bseplus/AnnualReport/524552/5245520310.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:58:59.268Z.